• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Breast cancer screening of mutation carriers in the era of COVID-19 pandemic.

作者信息

Toss Angela, Lambertini Matteo, Punie Kevin, Grandi Giovanni, Cortesi Laura

机构信息

Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.

Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology and Regenerative Medicine Relevance, University of Modena and Reggio Emilia, Modena, Italy.

出版信息

Int J Cancer. 2020 Dec 15;147(12):3574-3575. doi: 10.1002/ijc.33160. Epub 2020 Jul 1.

DOI:10.1002/ijc.33160
PMID:32557656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7323406/
Abstract
摘要

相似文献

1
Breast cancer screening of mutation carriers in the era of COVID-19 pandemic.2019冠状病毒病大流行时代突变携带者的乳腺癌筛查
Int J Cancer. 2020 Dec 15;147(12):3574-3575. doi: 10.1002/ijc.33160. Epub 2020 Jul 1.
2
Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.乳腺钼靶筛查与BRCA1和BRCA2突变携带者患乳腺癌的风险：一项前瞻性研究。
Breast Cancer Res Treat. 2014 Aug;147(1):113-8. doi: 10.1007/s10549-014-3063-y. Epub 2014 Aug 1.
3
Circulating cell-free DNA (cfDNA) levels in BRCA1 and BRCA2 mutation carriers: A preliminary study.BRCA1 和 BRCA2 基因突变携带者的循环无细胞 DNA（cfDNA）水平：一项初步研究。
Cancer Biomark. 2020;28(3):269-273. doi: 10.3233/CBM-190718.
4
Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.5 例在最初无疾病的 BRCA1 或 BRCA2 突变携带者中经筛查检出的乳腺癌病例。
Breast Cancer. 2019 Nov;26(6):846-851. doi: 10.1007/s12282-019-00971-6. Epub 2019 Apr 12.
5
Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution.BRCA1/2 基因突变筛查引入后乳腺癌手术方式的变化：单中心 158 例突变携带者的回顾性队列分析。
Ann Surg Oncol. 2011 Mar;18(3):745-51. doi: 10.1245/s10434-010-1381-9. Epub 2010 Oct 23.
6
Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.BRCA1 和 BRCA2 基因突变携带者行输卵管卵巢切除术后的乳腺癌筛查。
Breast Cancer Res Treat. 2011 Aug;129(1):157-64. doi: 10.1007/s10549-011-1423-4. Epub 2011 Mar 4.
7
[Breast cancer in BRCA1/2 mutation carriers].[携带BRCA1/2基因突变的乳腺癌患者]
Cesk Patol. 2016 Fall;52(4):206-209.
8
Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.BRCA1和BRCA2突变携带者的乳腺癌检测及肿瘤特征
Breast Cancer Res Treat. 2017 Jun;163(3):565-571. doi: 10.1007/s10549-017-4198-4. Epub 2017 Mar 25.
9
Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.60岁以上BRCA1和BRCA2突变携带者乳腺癌筛查的相关性和有效性：一项全国队列研究。
Int J Cancer. 2014 Dec 15;135(12):2940-9. doi: 10.1002/ijc.28941. Epub 2014 May 20.
10
Precision medicine meets public health: population screening for BRCA1 and BRCA2.精准医学与公共卫生相遇：BRCA1和BRCA2的人群筛查
J Natl Cancer Inst. 2014 Dec 30;107(1):420. doi: 10.1093/jnci/dju420. Print 2015 Jan.

本文引用的文献

1
The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?冠状病毒病（COVID-19）的性别影响：雌激素起作用吗？
Eur J Contracept Reprod Health Care. 2020 Jun;25(3):233-234. doi: 10.1080/13625187.2020.1766017. Epub 2020 May 29.
2
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.纽约市 5279 例 2019 年冠状病毒病患者住院和重症的相关因素：前瞻性队列研究。
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
3
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer.ESMO 管理和治疗适应 COVID-19 时代的建议：乳腺癌。
ESMO Open. 2020 May;5(Suppl 3):e000793. doi: 10.1136/esmoopen-2020-000793.
4
Call for ensuring cancer care continuity during COVID-19 pandemic.呼吁在新冠疫情期间确保癌症护理的连续性。
ESMO Open. 2020 May;5(3):e000783. doi: 10.1136/esmoopen-2020-000783.
5
Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic.COVID-19 大流行期间乳腺癌患者分诊、优先顺序和治疗的建议。
Breast. 2020 Aug;52:8-16. doi: 10.1016/j.breast.2020.04.006. Epub 2020 Apr 16.
6
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium.COVID-19 大流行期间乳腺癌患者的优先排序、治疗和分诊建议。COVID-19 大流行乳腺癌联盟。
Breast Cancer Res Treat. 2020 Jun;181(3):487-497. doi: 10.1007/s10549-020-05644-z. Epub 2020 Apr 24.
7
Breast Cancer Diagnosis, Treatment and Follow-Up During COVID-19 Pandemic.2019年冠状病毒病大流行期间的乳腺癌诊断、治疗及随访
Eur J Breast Health. 2020 Mar 25;16(2):86-88. doi: 10.5152/ejbh.2020.240320. eCollection 2020 Apr.
8
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective.在意大利 2019 冠状病毒病（COVID-19）传播期间的癌症护理：青年肿瘤学家的观点。
ESMO Open. 2020 Mar;5(2). doi: 10.1136/esmoopen-2020-000759.
9
Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival.筛查检出浸润性乳腺癌与症状性浸润性乳腺癌亚型分布的差异及其对生存的影响。
Clin Transl Oncol. 2017 Oct;19(10):1232-1240. doi: 10.1007/s12094-017-1660-z. Epub 2017 Apr 13.
10
Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership.诊断时的分期与卵巢癌生存：来自国际癌症基准合作计划的证据。
Gynecol Oncol. 2012 Oct;127(1):75-82. doi: 10.1016/j.ygyno.2012.06.033. Epub 2012 Jun 27.